Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation
Posted Date:
Aug 26, 2026
Sep 10, 2026
Awarded Date:
No Awarded Date
| SetAside Type | ||
| No Set aside used | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75F40126Q00382 | Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation | |
| Synopsis | ||
|
Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| FOOD AND DRUG ADMINISTRATION | Presolicitation | |
